Monday, December 23, 2024

Social & Scientific Systems (SSS) bolsters leadership team, adds Growth/Strategy leader and Clinical SME

Dr. Robert McLinden recently joined Social & Scientific Systems, Inc. (SSS) to lead Business Development and Strategy for SSS’ Clinical Research and Bioscience Group (CRB). Dr. McLinden has 27 years of experience in biomedical research with special emphasis on HIV vaccine development from the benchtop to the clinic. During this time, Dr. McLinden developed a wide array of skills in Molecular Biology, Cellular Biology and Cell Culture that led to a patent for the detection of RNA at the single copy level as well as a licensed cell line capable of supporting HIV-1 R5-utilizing virus replication.

Dr. Sliman, CRB’s Senior Director of Clinical Research, Infectious Diseases and Medical Director, also joined SSS recently. Dr. Sliman has more than 18 years of experience in clinical and public health research, including 10 years directing clinical projects and product development, in therapeutic areas such as gastroenterology, neurosciences, immunology, the microbiome, infectious diseases and vaccines.

SSS is a public health research organization providing solutions in clinical and biomedical research, epidemiology and public health research, health policy, and program evaluation.

Source: Social & Scientific Systems

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required